Oura Ring creator ŌURA has raised funding of more than $900m, earmarked for the growth of the company’s health technology offerings.
The investment, spearheaded by the Fidelity Management & Research Company, includes participation from ICONIQ, with Whale Rock and Atreides also contributing.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
This influx of capital, which places ŌURA’s valuation at an estimated $11bn, will also be directed towards the company’s advancements in AI, refining its product offerings and broadening its distribution on an international scale.
Last year, ŌURA announced revenues surpassing $500m, double the figure from the previous year.
The company said that it is on a trajectory to maintain this momentum, with expectations to double its revenue once more in 2025, potentially surpassing the $1bn mark in annual sales.
ŌURA CEO Tom Hale said: “This new funding is a testament to the strength of ŌURA’s business and the trust millions of members place in us every day. We are proud to be building not just a product, but a global movement toward proactive health – helping people understand their bodies, make better lifestyle decisions and connect more effectively with their healthcare providers.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“With this investment, we will accelerate innovation, expand our global reach and set a new standard for what wearables can achieve in advancing preventive health.”
In line with its expansion, ŌURA has announced a leadership transition, appointing David Shuman, founder of Lateralus Holdings and a board member since 2016, as the new board chair.
Shuman takes over from Eurie Kim, who has held the position since 2019. Moreover, the company is set to further strengthen its Board of Directors with the anticipated nomination of Matter Venture Partners’ founding managing partner Wen Hsieh.
The company recently expanded its product line, introducing the Oura Ring 4 Ceramic in a variety of colours, the Oura Ring 4 Charging Case, and Health Panels, which integrate lab test management within the Oura App.
In a strategic move into the consumer diabetes market, ŌURA unveiled a new glucose monitoring feature for its ring in May 2025, utilising data from Dexcom’s over-the-counter continuous glucose monitor Stelo.
